{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:19:48Z","timestamp":1792419588465,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study is performed to investigate the effects of adenovirus-mediated X-linked inhibitor of apoptosis protein (XIAP) overexpressed bone marrow mesenchymal stem cells (BMSCs) on brain injury in rats with cerebral palsy (CP).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Rat\u2019s BMSCs were cultured and identified. The XIAP gene of BMSCs was modified by adenovirus expression vector Ad-XIAP-GFP. The rat model of CP with ischemia and anoxia was established by ligating the left common carotid artery and anoxia for 2\u00a0h, and BMSCs were intracerebroventricularly injected to the modeled rats. The mRNA and protein expression of XIAP in brain tissue of rats in each group was detected by RT-qPCR and western blot analysis. The neurobehavioral situation, content of acetylcholine (Ach), activity of acetylcholinesterase (AchE), brain pathological injury, apoptosis of brain nerve cells and the activation of astrocytes in CP rats were determined via a series of assays.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Rats with CP exhibited obvious abnormalities, increased Ach content, decreased AchE activity, obvious pathological damage, increased brain nerve cell apoptosis, as well as elevated activation of astrocyte. XIAP overexpressed BMSCs improved the neurobehavioral situation, decreased Ach content and increased AchE activity, attenuated brain pathological injury, inhibited apoptosis of brain nerve cells and the activation of astrocytes in CP rats.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study demonstrates that XIAP overexpressed BMSCs can inhibit the apoptosis of brain nerve cells and the activation of astrocytes, increase AchE activity, and inhibit Ach content, so as to lower the CP caused by cerebral ischemia and hypoxia in rats.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12935-019-0988-6","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T11:07:15Z","timestamp":1571828835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of XIAP gene overexpressed bone marrow mesenchymal stem cells in the treatment of cerebral injury in rats with cerebral palsy"],"prefix":"10.1186","volume":"19","author":[{"given":"Wenjing","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghe","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"988_CR1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2872","author":"K Van Naarden Braun","year":"2016","unstructured":"Van Naarden Braun K, et al. Birth prevalence of cerebral palsy: a population-based study. Pediatrics. 2016. \n                    https:\/\/doi.org\/10.1542\/peds.2015-2872\n                    \n                  .","journal-title":"Pediatrics"},{"key":"988_CR2","first-page":"8","volume":"109","author":"P Rosenbaum","year":"2007","unstructured":"Rosenbaum P, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8\u201314.","journal-title":"Dev Med Child Neurol Suppl"},{"issue":"3","key":"988_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/PHM.0b013e3182063bc9","volume":"90","author":"AT Hirsh","year":"2011","unstructured":"Hirsh AT, et al. Survey results of pain treatments in adults with cerebral palsy. Am J Phys Med Rehabil. 2011;90(3):207\u201316.","journal-title":"Am J Phys Med Rehabil"},{"issue":"9","key":"988_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1682\/JRRD.2010.03.0024","volume":"47","author":"AT Hirsh","year":"2010","unstructured":"Hirsh AT, et al. Symptom burden in individuals with cerebral palsy. J Rehabil Res Dev. 2010;47(9):863\u201376.","journal-title":"J Rehabil Res Dev"},{"issue":"8","key":"988_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.braindev.2016.03.002","volume":"38","author":"A Kulak-Bejda","year":"2016","unstructured":"Kulak-Bejda A, et al. Stem cells therapy in cerebral palsy: a systematic review. Brain Dev. 2016;38(8):699\u2013705.","journal-title":"Brain Dev"},{"key":"988_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1479-5876-11-21","volume":"11","author":"G Chen","year":"2013","unstructured":"Chen G, et al. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J Transl Med. 2013;11:21.","journal-title":"J Transl Med"},{"issue":"8","key":"988_CR7","first-page":"580","volume":"43","author":"Z Luan","year":"2005","unstructured":"Luan Z, et al. Treatment of an infant with severe neonatal hypoxic\u2013ischemic encephalopathy sequelae with transplantation of human neural stem cells into cerebral ventricle. Zhonghua Er Ke Za Zhi. 2005;43(8):580\u20133 (discussion 580).","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"988_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1517\/14712598.2011.557060","volume":"11","author":"JE Carroll","year":"2011","unstructured":"Carroll JE, Mays RW. Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther. 2011;11(4):463\u201371.","journal-title":"Expert Opin Biol Ther"},{"key":"988_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1741-7015-9-52","volume":"9","author":"A Trounson","year":"2011","unstructured":"Trounson A, et al. Clinical trials for stem cell therapies. BMC Med. 2011;9:52.","journal-title":"BMC Med"},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1479-5876-10-100","volume":"10","author":"M Li","year":"2012","unstructured":"Li M, et al. Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells. J Transl Med. 2012;10:100.","journal-title":"J Transl Med"},{"issue":"12","key":"988_CR11","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jcyt.2013.06.001","volume":"15","author":"X Wang","year":"2013","unstructured":"Wang X, et al. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study. Cytotherapy. 2013;15(12):1549\u201362.","journal-title":"Cytotherapy"},{"issue":"5","key":"988_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/dmcn.13121","volume":"58","author":"B Dan","year":"2016","unstructured":"Dan B. Stem cell therapy for cerebral palsy. Dev Med Child Neurol. 2016;58(5):424.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"988_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/scd.2005.14.65","volume":"14","author":"X Long","year":"2005","unstructured":"Long X, et al. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev. 2005;14(1):65\u20139.","journal-title":"Stem Cells Dev"},{"issue":"Pt 19","key":"988_CR14","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1242\/jcs.01307","volume":"117","author":"A Hermann","year":"2004","unstructured":"Hermann A, et al. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci. 2004;117(Pt 19):4411\u201322.","journal-title":"J Cell Sci"},{"issue":"4","key":"988_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1634\/stemcells.2005-0370","volume":"24","author":"J Deng","year":"2006","unstructured":"Deng J, et al. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells. 2006;24(4):1054\u201364.","journal-title":"Stem Cells"},{"issue":"4","key":"988_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrm1621","volume":"6","author":"DL Vaux","year":"2005","unstructured":"Vaux DL, Silke J. IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol. 2005;6(4):287\u201397.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"988_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1203\/PDR.0b013e3181894a25","volume":"65","author":"R Askalan","year":"2009","unstructured":"Askalan R, et al. X-linked inhibitor of apoptosis protein expression after ischemic injury in the human and rat developing brain. Pediatr Res. 2009;65(1):21\u20136.","journal-title":"Pediatr Res"},{"issue":"12","key":"988_CR18","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1111\/j.1460-9568.2007.05948.x","volume":"26","author":"C Zhu","year":"2007","unstructured":"Zhu C, et al. X chromosome-linked inhibitor of apoptosis protein reduces oxidative stress after cerebral irradiation or hypoxia\u2013ischemia through up-regulation of mitochondrial antioxidants. Eur J Neurosci. 2007;26(12):3402\u201310.","journal-title":"Eur J Neurosci"},{"issue":"11","key":"988_CR19","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/stem.533","volume":"28","author":"A Mohr","year":"2010","unstructured":"Mohr A, et al. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells. Stem Cells. 2010;28(11):2109\u201320.","journal-title":"Stem Cells"},{"issue":"9","key":"988_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/01.WCB.0000080702.47016.FF","volume":"23","author":"A Saito","year":"2003","unstructured":"Saito A, et al. Interaction between XIAP and Smac\/DIABLO in the mouse brain after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2003;23(9):1010\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"988_CR21","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.leukres.2006.09.006","volume":"31","author":"X Wang","year":"2007","unstructured":"Wang X, et al. XIAP is upregulated in HL-60 cells cocultured with stromal cells by direct cell contact. Leuk Res. 2007;31(8):1125\u20139.","journal-title":"Leuk Res"},{"issue":"7","key":"988_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0387-7604(03)00039-1","volume":"25","author":"A Aydin","year":"2003","unstructured":"Aydin A, et al. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic\u2013ischemic brain injury. Brain Dev. 2003;25(7):494\u20138.","journal-title":"Brain Dev"},{"issue":"10","key":"988_CR23","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41419-018-1060-5","volume":"9","author":"B Wang","year":"2018","unstructured":"Wang B, et al. BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model. Cell Death Dis. 2018;9(10):1024.","journal-title":"Cell Death Dis"},{"issue":"9421","key":"988_CR24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/S0140-6736(04)16207-7","volume":"363","author":"LA Koman","year":"2004","unstructured":"Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet. 2004;363(9421):1619\u201331.","journal-title":"Lancet"},{"issue":"4","key":"988_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pediatrneurol.2010.11.009","volume":"44","author":"RL Holt","year":"2011","unstructured":"Holt RL, Mikati MA. Care for child development: basic science rationale and effects of interventions. Pediatr Neurol. 2011;44(4):239\u201353.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"988_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3727\/096368911X576036","volume":"21","author":"J Lundberg","year":"2012","unstructured":"Lundberg J, et al. Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression. Cell Transplant. 2012;21(1):333\u201343.","journal-title":"Cell Transplant"},{"issue":"2","key":"988_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pneurobio.2011.08.005","volume":"95","author":"CV Borlongan","year":"2011","unstructured":"Borlongan CV, et al. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol. 2011;95(2):213\u201328.","journal-title":"Prog Neurobiol"},{"issue":"4","key":"988_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/ten.tec.2010.0406","volume":"17","author":"T Hatlapatka","year":"2011","unstructured":"Hatlapatka T, et al. Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng Part C Methods. 2011;17(4):485\u201393.","journal-title":"Tissue Eng Part C Methods"},{"key":"988_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/978-1-60761-999-4_35","volume":"698","author":"D Sarkar","year":"2011","unstructured":"Sarkar D, et al. Cell surface engineering of mesenchymal stem cells. Methods Mol Biol. 2011;698:505\u201323.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"988_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2006.03.016","volume":"199","author":"KI Park","year":"2006","unstructured":"Park KI, et al. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol. 2006;199(1):179\u201390.","journal-title":"Exp Neurol"},{"issue":"2","key":"988_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/jnr.20436","volume":"80","author":"A Iwanami","year":"2005","unstructured":"Iwanami A, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res. 2005;80(2):182\u201390.","journal-title":"J Neurosci Res"},{"issue":"11","key":"988_CR32","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","volume":"25","author":"G Chamberlain","year":"2007","unstructured":"Chamberlain G, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739\u201349.","journal-title":"Stem Cells"},{"issue":"1","key":"988_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11064-011-0584-1","volume":"37","author":"H Ma","year":"2012","unstructured":"Ma H, et al. Neural stem cells over-expressing brain-derived neurotrophic factor (BDNF) stimulate synaptic protein expression and promote functional recovery following transplantation in rat model of traumatic brain injury. Neurochem Res. 2012;37(1):69\u201383.","journal-title":"Neurochem Res"},{"issue":"3","key":"988_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nn1405","volume":"8","author":"CP Hofstetter","year":"2005","unstructured":"Hofstetter CP, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci. 2005;8(3):346\u201353.","journal-title":"Nat Neurosci"},{"issue":"11\u201312","key":"988_CR35","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3727\/096368910X557236","volume":"20","author":"JY Lim","year":"2011","unstructured":"Lim JY, et al. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and beta-catenin phosphorylation and following transplantation into the developing brain. Cell Transplant. 2011;20(11\u201312):1855\u201366.","journal-title":"Cell Transplant"},{"issue":"6","key":"988_CR36","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang OY, et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57(6):874\u201382.","journal-title":"Ann Neurol"},{"issue":"21","key":"988_CR37","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.1523\/JNEUROSCI.20-21-07994.2000","volume":"20","author":"W Nakajima","year":"2000","unstructured":"Nakajima W, et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci. 2000;20(21):7994\u20138004.","journal-title":"J Neurosci"},{"issue":"2","key":"988_CR38","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1046\/j.1471-4159.2000.0750819.x","volume":"75","author":"C Zhu","year":"2000","unstructured":"Zhu C, et al. Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia. J Neurochem. 2000;75(2):819\u201329.","journal-title":"J Neurochem"},{"issue":"12","key":"988_CR39","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1523\/JNEUROSCI.19-12-05026.1999","volume":"19","author":"D Xu","year":"1999","unstructured":"Xu D, et al. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci. 1999;19(12):5026\u201333.","journal-title":"J Neurosci"},{"issue":"1","key":"988_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2004.01.014","volume":"16","author":"X Wang","year":"2004","unstructured":"Wang X, et al. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol Dis. 2004;16(1):179\u201389.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"988_CR41","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1093\/emboj\/20.12.3114","volume":"20","author":"J Silke","year":"2001","unstructured":"Silke J, et al. Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP. EMBO J. 2001;20(12):3114\u201323.","journal-title":"EMBO J"},{"issue":"1","key":"988_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.200108085","volume":"157","author":"J Silke","year":"2002","unstructured":"Silke J, et al. The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites. J Cell Biol. 2002;157(1):115\u201324.","journal-title":"J Cell Biol"},{"issue":"6","key":"988_CR43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1203\/01.pdr.0000246226.89215.a6","volume":"60","author":"R Askalan","year":"2006","unstructured":"Askalan R, et al. Astrocytic-inducible nitric oxide synthase in the ischemic developing human brain. Pediatr Res. 2006;60(6):687\u201392.","journal-title":"Pediatr Res"},{"issue":"5","key":"988_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/15216540215675","volume":"54","author":"G Lotocki","year":"2002","unstructured":"Lotocki G, Keane RW. Inhibitors of apoptosis proteins in injury and disease. IUBMB Life. 2002;54(5):231\u201340.","journal-title":"IUBMB Life"},{"issue":"19","key":"988_CR45","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1093\/emboj\/18.19.5242","volume":"18","author":"QL Deveraux","year":"1999","unstructured":"Deveraux QL, et al. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 1999;18(19):5242\u201351.","journal-title":"EMBO J"},{"issue":"24","key":"988_CR46","doi-asserted-by":"publisher","first-page":"9126","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000","volume":"20","author":"O Eberhardt","year":"2000","unstructured":"Eberhardt O, et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. J Neurosci. 2000;20(24):9126\u201334.","journal-title":"J Neurosci"},{"issue":"1","key":"988_CR47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1471-4159.1999.0720292.x","volume":"72","author":"M Simons","year":"1999","unstructured":"Simons M, et al. Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. J Neurochem. 1999;72(1):292\u2013301.","journal-title":"J Neurochem"},{"issue":"6","key":"988_CR48","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1046\/j.1471-4159.2000.0752288.x","volume":"75","author":"B Wagenknecht","year":"2000","unstructured":"Wagenknecht B, et al. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem. 2000;75(6):2288\u201397.","journal-title":"J Neurochem"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-019-0988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12935-019-0988-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-019-0988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T23:13:13Z","timestamp":1603321993000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-019-0988-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1186\/s12935-019-0988-6","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiment was approved by The First Affiliated Hospital of Zhengzhou University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}